Orthopädie Podologie Malgaroli & Werne AG – Trademark Portfolio

Entity Type: 25

Orthopädie Podologie Malgaroli & Werne AG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MOXXIS.

Mellingerstrasse 1

CH-5400 Baden

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MOXXIS
MOXXIS
Registered 2024

Trademark Classifications

Orthopädie Podologie Malgaroli & Werne AG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Orthopädie Podologie Malgaroli & Werne AG have?

Orthopädie Podologie Malgaroli & Werne AG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Orthopädie Podologie Malgaroli & Werne AG file in?

Orthopädie Podologie Malgaroli & Werne AG files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Orthopädie Podologie Malgaroli & Werne AG's most well-known trademarks?

Orthopädie Podologie Malgaroli & Werne AG's registered trademark portfolio includes well-known marks such as MOXXIS. These are among 1 currently registered trademark in the portfolio.

What is Orthopädie Podologie Malgaroli & Werne AG's trademark registration success rate?

Orthopädie Podologie Malgaroli & Werne AG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.